title: Marked clinical and jitter improvement after eculizumab in refractory myasthenia.
authors.affiliation: Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Vern C
authors.initials: VC
authors.lastname: Juel
authors.affiliation: Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Donald B
authors.initials: DB
authors.lastname: Sanders
authors.affiliation: Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Lisa D
authors.initials: LD
authors.lastname: Hobson-Webb
authors.affiliation: Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Janice M
authors.initials: JM
authors.lastname: Massey
authors.affiliation: Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Jeffrey T
authors.initials: JT
authors.lastname: Guptill
authors.affiliation: Department of Clinical Research, Alexion Pharmaceuticals, Cheshire, Connecticut, USA.|Department Global Medical Affairs, Alexion Pharmaceuticals, Cheshire, Connecticut, USA.
authors.forename: Fanny
authors.initials: F
authors.lastname: O'Brien
authors.affiliation: Department of Clinical Research, Alexion Pharmaceuticals, Cheshire, Connecticut, USA.|Department Global Medical Affairs, Alexion Pharmaceuticals, Cheshire, Connecticut, USA.
authors.forename: Jing Jing
authors.initials: JJ
authors.lastname: Wang
authors.affiliation: Department of Neurology, University of North Carolina, Chapel Hill, North Carolina, USA.
authors.forename: James F
authors.identifier: 0000-0002-7136-8617
authors.initials: JF
authors.lastname: Howard
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology / Q000627:therapeutic use*; D004576:Electromyography / Q000187:drug effects* / Q000639:trends; D006801:Humans; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab